Molecular Detection of Peripheral Blood Breast Cancer mRNA Transcripts as a Surrogate Biomarker for Circulating Tumor Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Lasa, Adriana ^a   Garcia, Arnal ^a   Alonso, Carmen ^a   Millet, Pilar ^a   Cornet, Mónica ^a   Cajal, Teresa Ramóny ^a,b   Baiget, Montserrat ^a   Barnadas, Agusti ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CAPECITABINE; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; TAXANE DERIVATIVE;

ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENRICHMENT CULTURE; EPCAM GENE; FEMALE; GENE ACTIVITY; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; KRT19 GENE; KRT20 GENE; MOLECULAR DYNAMICS; MUC1 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATIENT IDENTIFICATION; RNA ANALYSIS; RNA SEQUENCE; RNA TRANSCRIPTION; SCGB2 GENE; TFF1 GENE; TFF3 GENE;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84884224047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074079     Document Type: Article

References (31)

1. Pollan M, Pastor-Barriuso R, Ardanaz E, Argüelles M, Martos C, et al. (2009) Recent changes in breast cancer incidence in Spain 1098-2004. J Natl Cancer Inst 101: 1584-1591.
2. Early Breast Cancer Trialist's Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365: 1687-1717.
3. Chiang AC, Massagué J, (2008) Molecular basis of metastasis. N Engl J Med 359: 2814-23.
4. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, et al. (2004) Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer. N Engl J Med 351: 781-791.
5. Weigelt B, Bosma AJ, Hart AA, Rodenhuis S, van't Veer LJ, (2003) Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. Br J Cancer 88: 1091-4.
6. Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, et al. (2005) Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res 11: 3722-32.
7. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, et al. (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13: 688-95.
8. Mostert B, Sleijfer S, Foekens JA, Gratama JW, (2009) Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35: 463-74.
9. Alix-Panabières C, Pantel K, (2013) Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59 (1): 110-118.
10. Arya SK, Lim B, Rahman AR, (2013) Rahmana (2013) Enrichment, detection and clinical significance of circulating tumor cells. Lab Chip 13(11): 1995-2027.
11. Vona G, Sabile A, Louha M, Sitruk V, Romana S, et al. (2000) Isolation by size of epithelial tumor cells- A new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156: 57-63.
12. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, et al. (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 13: 920-8.
13. Zhao S, Liu Y, Zhang Q, Li H, Zhang M, et al. (2011) The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Res Treat 130: 809-16.
14. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, et al. (2007) Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System. Clin. Cancer Res. 13: 920-928.
15. Molloy TJ, Devriese LA, Helgason HH, Bosma AJ, Hauptmann M, et al. (2011) A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer. Br J Cancer 104: 1913-9.
16. Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, et al. (2008) Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 14: 2593-600.
17. Strati A, Markou A, Parisi C, Politaki E, Mavroudis D, et al. (2011) Gene expresión profile of circulating tumor cells in breast cancer by RT-PCR. BMC Cancer 11: 422.
18. Molloy TJ, Roepman P, Naume B, van't Veer LJ, (2012) A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients. PLoS One 7(2): e32426.
19. Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, et al. (2010) Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer 10: 666.
20. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, et al. (2002) Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20: 3404-12.
21. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, et al. (1999) Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59: 3028-31.
22. Müller V, Pantel K, (2009) HER2 as a marker for the detection of circulating tumor cells. Breast Cancer Res Treat 117: 535-537.
23. Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, et al. (2008) Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett 263: 267-79.
24. May FE, (2012) The potential of trefoil proteins as biomarkers in human cancer. Biomark Med 6: 301-4.
25. Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, et al. (2009) Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat 118: 455-468.
26. Grünewald K, Haun M, Urbanek M, Fiegl M, Müller-Holzner E, et al. (2000) Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest 80: 1071-7.
27. Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, et al. (2000) RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters. Breast Cancer Res Treat 60: 143-51.
28. You F, Roberts LA, Kang SP, Nunes RA, Dias C, et al. (2008) Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells. J Hematol Oncol 1: 2.
29. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, et al. (1999) Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 17: 2015-9.
30. Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, et al. (2010) Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 102: 276-84.
31. Hauch S, Zimmermann S, Lankiewicz S, Zieglschmid V, Böcher O, et al. (2007) The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. Anticancer Res 27: 1337-41.